[ad_1]
The European Commission announced Wednesday that it has reached an agreement with the US company Pfizer and the German vaccine manufacturer BioNTech to ship four million doses of the coronavirus vaccine to the European Union by the end of this month.
To overcome aggressive mutations in the virus and improve the position of the focal points, we must act quickly and efficiently.
Reuters quotes what the President of the European Commission, Ursula von der Leyen, said.
With these four million doses of vaccine, two million people can be vaccinated. The EU will receive them in addition to what it has agreed so far with the manufacturers. According to the Commission’s communications, the number of cases has increased considerably in recent weeks in the following regions: Tyrol, Austria, Moselle in France, Bolzano, Italy and the two German provinces of Bavaria and Saxony.
The vaccines, which will arrive in March, will be used specifically to help focal points, especially in border regions, so that the free movement of products and people can be restored as soon as possible.
A contract for this was already signed at the end of November last year.
[ad_2]
